Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

LDL Apheresis for the Treatment of Congestive Heart Failure

NCT00510601 is registered in ClinicalTrials.gov with Patrick Moriarty, MD, FACP, FACC as lead sponsor.

NCT NCT00510601
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00510601 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
LDL Apheresis for the Treatment of Congestive Heart Failure
Lead sponsor
Patrick Moriarty, MD, FACP, FACC
Phase
Phase 1
Overall status
Completed
Start date
July 31, 2007
Completion date
July 31, 2011
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart decompensation